ADVFN Logo
Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

PHIO Phio Pharmaceuticals Corporation

0.735
-0.0519 (-6.60%)
May 20 2024 - Closed
Delayed by 15 minutes

Period:

Draw Mode:

Volume 247,642
Bid Price 0.70
Ask Price 0.785
News (2)
Day High 0.7899

Low
0.50

52 Week Range

High
5.29

Day Low 0.74
Company Name Stock Ticker Symbol Market Type
Phio Pharmaceuticals Corporation PHIO NASDAQ Common Stock
  Price Change Change Percent Stock Price Last Traded
-0.0519 -6.60% 0.735 19:58:44
Open Price Low Price High Price Close Price Prev Close
0.7897 0.74 0.7899 0.7839 0.7869
Trades Volume VWAP Dollar Volume Avg Volume 52 Week Range
712 247,642 $ 0.7652752 $ 189,514 - 0.50 - 5.29
Last Trade Time Type Quantity Stock Price Currency
19:58:43 formt 316 $ 0.735 USD

Phio Pharmaceuticals Corporation Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
1.91M 2.44M - 0 -10.83M -4.43 -
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- - - -

more financials information »

Phio Pharmaceuticals News

Loading Messages....

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....


No posts yet, be the first! No PHIO Message Board. Create One! See More Posts on PHIO Message Board See More Message Board Posts

Historical PHIO Price Data

Period Open High Low VWAP Avg. Daily Vol Change %
1 Week0.70090.84010.65120.762706124,3400.03414.87%
1 Month0.631.050.61010.8083162528,5770.10516.67%
3 Months0.85251.150.6048490.8646279404,581-0.1175-13.78%
6 Months0.992.090.501.14529,911-0.255-25.76%
1 Year4.255.290.501.86531,929-3.52-82.71%
3 Years24.1229.640.5014.58673,228-23.39-96.95%
5 Years5.472130.200.5019.06727,551-4.74-86.57%

Phio Pharmaceuticals Description

Phio Pharmaceuticals Corp is a US-based biotechnology company. It is principally engaged in developing immuno-oncology therapeutics based on its proprietary self-delivering RNAi platform and Samcyprone, a topical immunomodulator, which addresses significant unmet medical needs. The company's pipeline products include PH-762, PH-804, PH-790, and others.